R Baldelli1, E Nicastri2, N Petrosillo2, L Marchioni2, A Gubbiotti3, I Sperduti4, P Di Giacinto1, L Rizza1, F Rota1, M Franco5, A Lania6, G Aimaretti7, G Ippolito2, P Zuppi1. 1. Endocrinology Unit, Department of Oncology and Medical Specialities, A.O. San Camillo Forlanini, Rome, Italy. 2. National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Rome, Italy. 3. Biochemical Clinical Unit, A.O. San Camillo Forlanini, Rome, Italy. 4. Biostatistical Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. 5. Endocrinology Unit, Department of Oncology and Medical Specialities, A.O. San Camillo Forlanini, Rome, Italy. martafranco220@gmail.com. 6. Endocrinology, Diabetology and Andrology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, MI, Italy. 7. SCDU of Endocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Abstract
PURPOSE: "Non thyroidal illness syndrome" (NTIS) or "euthyroid sick syndrome" (ESS) is a possible biochemical finding in euthyroid patients with severe diseases. It is characterized by a reduction of serum T3 (fT3), sometimes followed by reduction of serum T4 (fT4). The relationship between thyroid hormones levels and mortality is well known and different studies showed a direct association between NTIS and mortality. The sudden spread of the 2019 novel coronavirus (SARS-CoV 2) infection (COVID-19) and its high mortality become a world healthcare problem. Our aim in this paper was to investigate if patients affected by COVID-19 presented NTIS and the relationship between thyroid function and severity of this infection. METHODS: We evaluated the thyroid function in two different groups of consecutive patients affected by COVID-19 with respect to a control group of euthyroid patients. Group A included patients hospitalized for COVID-19 pneumonia while patients requiring intensive care unit (ICU) for acute respiratory syndrome formed the group B. Group C identified the control group of euthyroid patients. RESULTS: Patients from group A and group B showed a statistically significant reduction in fT3 and TSH compared to group C. In group B, compared to group A, a further statistically significant reduction of fT3 and TSH was found. CONCLUSIONS: COVID-19 in-patients can present NTIS. FT3 and TSH serum levels are lower in patients with more severe symptoms.
PURPOSE: "Non thyroidal illness syndrome" (NTIS) or "euthyroid sick syndrome" (ESS) is a possible biochemical finding in euthyroid patients with severe diseases. It is characterized by a reduction of serum T3 (fT3), sometimes followed by reduction of serum T4 (fT4). The relationship between thyroid hormones levels and mortality is well known and different studies showed a direct association between NTIS and mortality. The sudden spread of the 2019 novel coronavirus (SARS-CoV 2) infection (COVID-19) and its high mortality become a world healthcare problem. Our aim in this paper was to investigate if patients affected by COVID-19 presented NTIS and the relationship between thyroid function and severity of this infection. METHODS: We evaluated the thyroid function in two different groups of consecutive patients affected by COVID-19 with respect to a control group of euthyroid patients. Group A included patients hospitalized for COVID-19 pneumonia while patients requiring intensive care unit (ICU) for acute respiratory syndrome formed the group B. Group C identified the control group of euthyroid patients. RESULTS:Patients from group A and group B showed a statistically significant reduction in fT3 and TSH compared to group C. In group B, compared to group A, a further statistically significant reduction of fT3 and TSH was found. CONCLUSIONS:COVID-19 in-patients can present NTIS. FT3 and TSH serum levels are lower in patients with more severe symptoms.
Authors: David Tak Wai Lui; Chi Ho Lee; Wing Sun Chow; Alan Chun Hong Lee; Anthony Raymond Tam; Polly Pang; Tip Yin Ho; Chloe Yu Yan Cheung; Carol Ho Yi Fong; Chun Yiu Law; Kelvin Kai Wang To; Ching Wan Lam; Kathryn Choon Beng Tan; Yu Cho Woo; Ivan Fan Ngai Hung; Karen Siu Ling Lam Journal: Front Endocrinol (Lausanne) Date: 2022-01-13 Impact factor: 5.555
Authors: C Sparano; E Zago; A Morettini; C Nozzoli; D Yannas; V Adornato; E Caldini; M Vaudo; M Maggi; L Petrone Journal: J Endocrinol Invest Date: 2021-12-01 Impact factor: 5.467
Authors: C Okoye; F Niccolai; S Rogani; B Lemmi; U Peta; S Del Vecchio; V Morelli; N Caraccio; V Calsolaro; F Monzani Journal: J Endocrinol Invest Date: 2022-05-11 Impact factor: 5.467